X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. PANACEA BIOTECH FDC LTD./
PANACEA BIOTECH
 
P/E (TTM) x 21.2 -19.7 - View Chart
P/BV x 4.8 2.3 205.0% View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 FDC LTD.   PANACEA BIOTECH
EQUITY SHARE DATA
    FDC LTD.
Mar-14
PANACEA BIOTECH
Mar-14
FDC LTD./
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs144149 96.5%   
Low Rs7982 96.0%   
Sales per share (Unadj.) Rs47.684.1 56.5%  
Earnings per share (Unadj.) Rs7.6-18.3 -41.6%  
Cash flow per share (Unadj.) Rs9.0-6.7 -134.5%  
Dividends per share (Unadj.) Rs2.250-  
Dividend yield (eoy) %2.00-  
Book value per share (Unadj.) Rs47.583.7 56.8%  
Shares outstanding (eoy) m177.8361.25 290.3%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.31.4 170.4%   
Avg P/E ratio x14.6-6.3 -231.7%  
P/CF ratio (eoy) x12.3-17.2 -71.6%  
Price / Book Value ratio x2.31.4 169.6%  
Dividend payout %29.60-   
Avg Mkt Cap Rs m19,7847,074 279.7%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m1,2211,449 84.2%   
Avg. sales/employee Rs ThNM1,874.1-  
Avg. wages/employee Rs ThNM527.0-  
Avg. net profit/employee Rs ThNM-407.7-  
INCOME DATA
Net Sales Rs m8,4595,154 164.1%  
Other income Rs m394100 394.3%   
Total revenues Rs m8,8525,254 168.5%   
Gross profit Rs m2,070-766 -270.2%  
Depreciation Rs m249711 35.0%   
Interest Rs m311,503 2.1%   
Profit before tax Rs m2,184-2,881 -75.8%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m-225-6 3,945.6%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m60617 3,604.5%   
Profit after tax Rs m1,353-1,121 -120.7%  
Gross profit margin %24.5-14.9 -164.6%  
Effective tax rate %27.7-0.6 -4,754.8%   
Net profit margin %16.0-21.8 -73.5%  
BALANCE SHEET DATA
Current assets Rs m4,3553,810 114.3%   
Current liabilities Rs m1,7928,365 21.4%   
Net working cap to sales %30.3-88.4 -34.3%  
Current ratio x2.40.5 533.6%  
Inventory Days Days44156 28.6%  
Debtors Days Days2567 36.7%  
Net fixed assets Rs m3,02514,480 20.9%   
Share capital Rs m17961 291.4%   
"Free" reserves Rs m8,243903 912.7%   
Net worth Rs m8,4535,127 164.9%   
Long term debt Rs m115,832 0.2%   
Total assets Rs m10,55719,433 54.3%  
Interest coverage x71.4-0.9 -7,792.2%   
Debt to equity ratio x01.1 0.1%  
Sales to assets ratio x0.80.3 302.1%   
Return on assets %13.12.0 667.5%  
Return on equity %16.0-21.9 -73.2%  
Return on capital %23.53.6 646.5%  
Exports to sales %13.324.5 54.3%   
Imports to sales %3.310.2 32.8%   
Exports (fob) Rs m1,1261,264 89.1%   
Imports (cif) Rs m283525 53.9%   
Fx inflow Rs m1,1461,539 74.5%   
Fx outflow Rs m355942 37.7%   
Net fx Rs m791597 132.4%   
CASH FLOW
From Operations Rs m1,485599 247.8%  
From Investments Rs m-620-438 141.5%  
From Financial Activity Rs m-753-303 248.7%  
Net Cashflow Rs m113-141 -79.8%  

Share Holding

Indian Promoters % 68.9 74.5 92.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 0.6 783.3%  
FIIs % 7.5 1.3 576.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 23.6 80.5%  
Shareholders   23,730 10,259 231.3%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   PFIZER  ABBOTT INDIA  PLETHICO PHARMA  ALEMBIC LTD  MERCK LTD  

Compare FDC LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade in Red, Oil on the Boil, and Top Stocks in Action(Pre-Open)

The BSE Sensex closed lower by 53 points to end the day at 36,305. While the broader NSE Nifty ended the day down by 136 points to end at 10,975.

Related Views on News

FDC LTD. Announces Quarterly Results (1QFY19); Net Profit Up 74.5% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, FDC LTD. has posted a net profit of Rs 511 m (up 74.5% YoY). Sales on the other hand came in at Rs 3 bn (up 16.7% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (4QFY18); Net Profit Down 35.8% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, FDC LTD. has posted a net profit of Rs 315 m (down 35.8% YoY). Sales on the other hand came in at Rs 3 bn (up 5.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

How IL&FS Rating Downgrade Will Impact Your Mutual Funds...(Outside View)

Sep 17, 2018

PersonalFN explains the impact of IL&FS rating downgrade on mutual funds.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Sep 24, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS